SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Stine Seed Farm, Inc. (Last) (First) (Middle) 22555 LAREDO TRAIL (Street) ADEL IA 50003 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 11/10/2011	3. Issuer Name and Ticker or Trading Symbol NEWLINK GENETICS CORP [ NLNK ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	178,571	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series B Preferred Stock	(1)	(1)	Common Stock	1,760,000	(1)	D
Series C Preferred Stock	(2)	(2)	Common Stock	1,000,000	(2)	D
Series D Preferred Stock	(3)	(3)	Common Stock	1,500,000	(3)	D
Series E Preferred Stock	(4)	(4)	Common Stock	320,000	(4)	D

Explanation of Responses:

1. Every one share of Series B Preferred Stock will automatically convert into 0.476 shares of common stock upon the closing of the Issuer's initial public offering.

2. Every one share of Series C Preferred Stock will automatically convert into 0.534 shares of common stock upon the closing of the Issuer's initial public offering, subject to anti-dilution adjustments.

3. Every one share of Series D Preferred Stock will automatically convert into 0.534 shares of common stock upon the closing of the Issuer's initial public offering, subject to anti-dilution adjustments.

4. Every one share of Series E Preferred Stock will automatically convert at a price equal to (1) the product of (A) the price at which the shares of common stock are sold to the public in Issuer's initial public offering and (B) 0.85 (as adjusted to reflect any adjustments to the Series E conversion price occurring prior to any such adjustment occurring in connection with the Issuer's initial public offering if it closes on or before December 31, 2011, or (2) $6.25 per common share under any other conversion scenario.

	/s/ Jerald L. Reichling	11/09/2011
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.